Group 1 - Huayang Intelligent's shareholder, Fosun Weiying, plans to reduce its stake by up to 285.42 million shares, representing no more than 5% of the company [1] - Kangtai Biological's controlling shareholder's concerted actor, Du Xinglian, intends to reduce its stake by up to 272.4 million shares, which is no more than 0.24% of the total share capital [2] - Mindray Medical has submitted an application for H-share issuance and listing on the Hong Kong Stock Exchange [4] Group 2 - Junpu Intelligent's chairman, Liu Yuan, resigned for personal reasons, and Wang Jianfeng was elected as the new chairman [6] - Mingchen Health's actual controller and executives plan to collectively reduce their stake by up to 8.61 million shares, accounting for 3.27% of the total share capital [7] - Zhongheng Design's directors and executives plan to reduce their stake by up to 151.57 million shares, representing no more than 0.55% of the total share capital [9] Group 3 - ST Erya and its actual controller, Zheng Jiping, are still under investigation by the China Securities Regulatory Commission [10] - Qicai Chemical's shareholder, Beijing Fengyan, plans to reduce its stake by up to 399.12 million shares, accounting for 0.98% of the total share capital [11] - Aier Eye Hospital plans to distribute a cash dividend of 0.8 yuan per 10 shares to all shareholders, totaling approximately 744 million yuan [12] Group 4 - Meiri Interactive's actual controller's concerted actor plans to reduce its stake by up to 394.74 million shares, which is 1% of the total share capital [13] - Maipu Medical's pre-IPO shareholder plans to reduce its stake by up to 67.05 million shares, representing no more than 1% of the total share capital [15] - Qinchuan Machine Tool's subsidiary plans to increase its registered capital from 50 million yuan to 200 million yuan, introducing new investors [17] Group 5 - Guiyang Bank's proposed director, Yu Rui, has resigned due to work reasons [19] - Guiyang Bank plans to acquire Xifeng Development Village Bank and establish a branch [20] - Aojing Medical's directors and executives plan to collectively reduce their stake by up to 25.28 million shares, accounting for no more than 0.19% of the total share capital [21] Group 6 - Zhongji Xuchuang intends to issue H-shares and list on the Hong Kong Stock Exchange [22] - ST Huatuo's stock will have its risk warning lifted, changing its name to Shiji Huatuo [25] - *ST Gaohong's stock has been delisted from the Shenzhen Stock Exchange [27] Group 7 - Tianwo Technology plans to publicly transfer a 7.12% stake in Qinghai Haihe Railway Transportation Co., with an assessed value of approximately 8.54 million yuan [28] - Xingye Technology's major shareholder plans to reduce its stake by up to 886.65 million shares, representing no more than 3% of the total share capital [29] - Jiangnan Chemical has successfully acquired 100% equity of Chongqing Shun'an Explosive Materials Co., with a transfer base price of 1 billion yuan [31]

Core Viewpoint - Multiple shareholders and actual controllers of various companies are planning to reduce their stakes, indicating potential shifts in ownership and market sentiment [1] Shareholder Reductions - Daily Interaction's actual controller's concerted actor plans to reduce holdings by no more than 1% [1] - MaiPu Medical's shareholder Guoshou Chengda intends to reduce holdings by no more than 1% [1] - New Open Source's director Hua Mengyang plans to reduce holdings by no more than 2 million shares [1] - Colorful Chemistry's shareholder Beijing Fengyan aims to reduce holdings by no more than 0.9829% [1] - Mingchen Health's actual controller Chen Qinfang plans to reduce holdings by no more than 3% [1] - Huayang Intelligent's shareholder Fosun Weiying intends to reduce holdings by no more than 5% [1] - Hesheng Silicon Industry's shareholder Fuda Industrial plans to reduce holdings by no more than 27.0705 million shares [1] - Lianying Laser's actual controller Niu Zengqiang plans to reduce holdings by no more than 3 million shares [1] - Sanmei Co., Ltd.'s controlling shareholder and actual controller Hu Rongda intends to reduce holdings by no more than 3% [1] - Zhongzhou Special Materials' actual controller Feng Mingming plans to reduce holdings by no more than 1.22% [1] - Shoulu Hotel's Ctrip Shanghai has reduced holdings by 2.26% [1] Other Notable Events - *ST Gao Hong's stock is set to be delisted and removed from trading [1] - *ST Yuancheng has received a notice regarding the proposed termination of its stock listing [1]

Core Points - The company announced that its major shareholder, Beijing Fengyan Investment Management Co., Ltd., plans to reduce its stake in the company by selling up to 3,991,156 shares within three months after the announcement [1] Summary by Category Shareholder Information - Beijing Fengyan holds 24,000,000 shares, representing 5.9108% of the company's total share capital, or 6.0133% when excluding repurchased shares [1] - The planned reduction of shares constitutes 0.9829% of the total share capital and 1.0000% when excluding repurchased shares, which is 16.6298% of Beijing Fengyan's total holdings [1]

Summary of Key Points Core Viewpoint - On November 10, several A-share listed companies disclosed their shareholding changes, with some announcing share buybacks while others reported share reductions by major shareholders [1]. Group 1: Share Buybacks - Hangcai Co. proposed to use 50 million to 100 million yuan of surplus funds for share repurchase [2]. - Sunong Bank executives plan to increase their holdings by no less than 1.8 million yuan in A-shares within six months [2]. - Jiangsu Cable's controlling shareholder received loan support for increasing A-share holdings [2]. Group 2: Share Reductions - A total of 25 A-share listed companies announced share reductions, including: - Aojing Medical plans to reduce no more than 0.19% of its shares by directors and executives [2]. - Maipu Medical's shareholder Guoshou Chengda intends to reduce no more than 1% of its shares [2]. - Shoulv Hotel's Ctrip Shanghai reduced 25.206 million shares on November 10 [2]. - Mingchen Health's controlling shareholder plans to reduce no more than 3% of the total share capital [2]. - Meiri Interactive's shareholder "I Got a Push" intends to reduce no more than 1% of its shares [2]. - Qicai Chemical's shareholder Beijing Fengyan plans to reduce no more than 0.98% of its shares [2]. - Other companies with planned reductions include Zhongheng Design, Xin Kaipu, Lianying Laser, Hongxin Electronics, and others, with reductions ranging from 0.07% to 5% [2].

Core Viewpoint - Beijing Fengyan Investment Management Co., Ltd. plans to reduce its stake in Qicai Chemical (300758.SZ) by selling up to 3.9912 million shares, representing approximately 0.9829% of the total share capital [1] Group 1 - Beijing Fengyan holds 24 million shares of Qicai Chemical, accounting for 5.9108% of the total share capital, or 6.0133% when excluding repurchased shares [1] - The planned reduction will occur within three months after the announcement, starting 15 trading days from the date of disclosure [1] - The reduction represents 16.6298% of the shares held by Beijing Fengyan [1]

Core Viewpoint - Beijing Fengyan Investment Management Co., Ltd. plans to reduce its stake in Qicai Chemical by selling up to 3.9912 million shares, representing approximately 0.9829% of the total share capital [1] Group 1: Shareholding Details - Beijing Fengyan holds 24 million shares of Qicai Chemical, accounting for 5.9108% of the total share capital [1] - After excluding repurchased shares, the stake represents 6.0133% of the adjusted total share capital [1] Group 2: Reduction Plan - The planned reduction will occur within three months after the announcement, starting 15 trading days from the disclosure date [1] - The reduction will account for 16.6298% of Beijing Fengyan's total holdings in Qicai Chemical [1]

Core Viewpoint - Beijing Fengyan Investment Management Co., Ltd. plans to reduce its stake in Qicai Chemical by up to approximately 3.99 million shares, representing about 0.98% of the total share capital, which may impact the company's stock performance and investor sentiment [1] Company Summary - Qicai Chemical (SZ 300758) announced that its major shareholder, Beijing Fengyan, holds 24 million shares, accounting for approximately 5.91% of the total share capital [1] - The planned reduction of shares by Beijing Fengyan represents about 16.63% of its total holdings in Qicai Chemical [1] - As of the announcement, Qicai Chemical's market capitalization is 5.8 billion yuan [1] - The company's revenue composition for the year 2024 is entirely from fine chemicals, with a 100% contribution from this segment [1]

Core Viewpoint - Beijing Fengyan Investment Management Co., Ltd. plans to reduce its stake in Qicai Chemical by up to 3.9912 million shares, representing 0.98% of the company's total share capital [1] Group 1 - The shareholder, holding 5.9108% of Qicai Chemical, intends to execute the share reduction through centralized bidding [1] - The reduction will account for 1% of the company's total share capital after excluding shares held in the repurchase account [1]

Core Viewpoint - Beijing Fengyan Investment Management Co., Ltd. plans to reduce its stake in Qicai Chemical (300758.SZ) by selling up to 3,991,156 shares, representing approximately 0.9829% of the total share capital [1] Group 1 - Beijing Fengyan holds 24,000,000 shares in Qicai Chemical, accounting for 5.9108% of the total share capital, or 6.0133% when excluding repurchased shares [1] - The planned reduction will occur within three months after a 15 trading day period following the announcement [1] - The reduction represents 16.6298% of the shares held by Beijing Fengyan [1]

Core Viewpoint - Beijing Fengyan Investment Management Co., Ltd. plans to reduce its stake in Qicai Chemical by selling up to 3.9912 million shares, representing 0.9829% of the total share capital, from December 2, 2025, to February 27, 2026 [1] Group 1 - Beijing Fengyan Investment Management Co., Ltd. holds 24 million shares of Qicai Chemical, accounting for 5.9108% of the total shares, and 6.0133% after excluding repurchased shares [1] - The planned reduction in shares represents 16.6298% of Beijing Fengyan's total holdings [1]